| Typicality: | 0.406 |
| Saliency: | 0.366 |
| with an eye to therapy development | 5 | purpose |
| in their papers | 3 | location |
| colleague → study → mouse | 15 |
| negative | neutral | positive |
| 0.191 | 0.760 | 0.049 |
| Raw frequency | 15 |
| Normalized frequency | 0.366 |
| Modifier score | 0.500 |
| Perplexity | 479.176 |